Anti‐MRSA Agent Discovery Using Diversity‐Oriented Synthesis

Gemma L. Thomas, Richard J. Spandl, Freija G. Glansdorp et al. · Angewandte Chemie International Edition · 2008

Beating the superbugs: Diversity-oriented synthesis using a solid-supported phosphonate unit to synthesize 242 drug-like compounds based on 18 natural-product-like scaffolds led to the discovery of gemmacin (see scheme). This new structural class of antibiotic is active towards methicillin-resistant Staphylococcus aureus (MRSA).

Cited by 134 works. doi:10.1002/anie.200705415

Authors

References